Press releases

Future focus: 3 tools for launching fast in the face of uncertainty

Imagine you had a crystal ball which allowed you to see into the future and understand exactly how your life science launch would pan out. You could see the barriers that would impact your clinical trials, the siloes slowing down decision making, and even look far into the horizon to understand how your product launch …

Future focus: 3 tools for launching fast in the face of uncertainty Read More »

Are You Speaking a Patient’s Language?: 5 Terms Used By Patients

Health journeys can be complex, sometimes more complex than a Rube Goldberg machine or spelling, say, embourgeoisement or consanguineous. And certain aspects of living with a chronic health condition – be that a symptom, side effect, emotional experience or other quality of life impact – can be hard to put into words. Over time, especially …

Are You Speaking a Patient’s Language?: 5 Terms Used By Patients Read More »

Identifying And Engaging Digital Opinion Leaders

Digital Opinion Leaders (DOLs) and KOLs overlap, but each group is unique.  Unlike traditional KOLs, DOLs have a different reach and a unique voice because they know how to effectively use multiple mediums to either create their own content or share, thus establishing their presence within a growing digital ecosystem. For DOLs, there is often …

Identifying And Engaging Digital Opinion Leaders Read More »

Release of International Book: “DTx An Opportunity for Italy and Beyond”

Originally aimed at Italy, the new international edition of the book curated by a panel of Digital Therapeutics experts covers the global DTx landscape, from R&D to scientific validation and go-to-market aspects. Milan, Italy | October 5, 2021 – Originally published in January 2021 for Italian audiences, the international, updated version of “DTx: An Opportunity …

Release of International Book: “DTx An Opportunity for Italy and Beyond” Read More »

An overview of CDISC standards

Formedix has been strong advocates for the use of CDISC data standards in clinical and non-clinical research for decades, ever since we realized how it could transform our business by enabling the rapid design and build of clinical trials. We quickly focused our company around the use of CDISC standards, and are now industry leaders …

An overview of CDISC standards Read More »

Why switch to automated CRF annotations?

What is an annotated CRF? An annotated CRF documents the location in a database of the data collected for each question on a form. In other words, it’s a mapping between each item on a form to its corresponding variable contained within the corresponding dataset. Annotated CRFs are part of the mandatory CDISC submission deliverables …

Why switch to automated CRF annotations? Read More »

P360 Boosts ZING SMS Communication Module with Multimodal Enterprise-Grade Features

Innovative new UCaaS platform powers sales teams with compliant SMS text messaging, call triggering, asset delivery, activity tracking and more P360, a leading developer of technology for life sciences companies, today announced that its ZING Communication Module has been enhanced with several new enterprise-grade unified communication features. Not only does the ZING unified communications as …

P360 Boosts ZING SMS Communication Module with Multimodal Enterprise-Grade Features Read More »

Identifying KOLs in Growing and Emerging Markets

The process of discovering HCPs who are leading key opinion leaders (KOLs) in emerging and growing markets is not as straightforward as it is in other countries. When identifying KOLs within emerging markets, the need to conduct solid, primary research becomes paramount.  Relying solely on the typical quantitative methodologies such as examining publications, citations, clinical …

Identifying KOLs in Growing and Emerging Markets Read More »

Social Health: The New Patient Journey

Access to online social connections has transformed the patient journey, and your brand strategy can evolve with it to effectively meet patients where they are. Health Union recently surveyed 2,371 patients across a diverse representation of health conditions to better understand how social health – the digital means by which health consumers engage with each other …

Social Health: The New Patient Journey Read More »

RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare

RwHealth, the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceutical companies.   RwHealth’s unique Data Science Platform combines Artificial Intelligence (AI), Machine Learning and Data Science to give healthcare providers …

RwHealth, the Artificial Intelligence provider for the NHS, promises to transform healthcare Read More »

2021 PM Society Digital Awards – Winners Announced

Havas Life Medicom, ARK and Pharmadoctor top the agency charts AstraZeneca, klarify and Novartis Gene Therapies top the pharma leader board The Digital Awards is in its 12th year and celebrates the best in digital communications within the pharmaceutical and healthcare sectors. Judges include experts from digital, creative and communications agencies, digital specialists and marketers …

2021 PM Society Digital Awards – Winners Announced Read More »

Taking a de-centralized approach to cure the Hepatitis C epidemic

This year’s World Hepatitis Day theme, ‘Hepatitis Can’t Wait,’ stresses the urgency of testing and treating viral hepatitis, as well as removing the stigma surrounding the disease and providing support for patients. Treatment for hepatitis C has evolved dramatically over the past decade. The introduction of direct-acting-antivirals has revolutionized the treatment landscape, leading the World …

Taking a de-centralized approach to cure the Hepatitis C epidemic Read More »

Using NCI controlled terminology for standardizing data

The use of consistent terminology within and between studies is critical to enabling an efficient trial process. CDISC standards such as CDASH, SDTM, SEND and ADaM standardize the structures to use when collecting and submitting data, but what about the data values themselves? This article gives an overview of CDISC’s standardized controlled terminology and how it …

Using NCI controlled terminology for standardizing data Read More »

Pathway To Effective Stakeholder Mapping

Before developing any stakeholder engagement plan, it is crucial to have a clear understanding of all the relevant individuals and groups your product or device could directly impact or interest in some way. Stakeholders within the pharmaceutical world encompass many diverse groups and include payers, government bodies, standard-setting bodies, physicians, key opinion leaders, patients, and …

Pathway To Effective Stakeholder Mapping Read More »

Social Health: The Future of Healthcare Marketing

With advertisers preparing to spend up to $15 billion on influencer marketing by 2022, pharmaceutical and biotech companies are increasingly (and carefully) engaging trusted health social influencers to connect more authentically with consumers. As pharma starts to leverage a multitude of high-engagement channels like influencer marketing, online communities and virtual health services, the industry finds itself …

Social Health: The Future of Healthcare Marketing Read More »

Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester

Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) in Manchester. The facility, which was closed in 2020, includes the multi-million pound cyclotron, one of only a handful in the UK. It will supply hard-to-make radiochemicals to drug discovery biotechs and academic innovators – increasing the UK’s …

Medicines Discovery Catapult relaunches Wolfson Radiochemistry facility in Manchester Read More »

Measuring Advocacy of Digital KOLs

Identifying the most important & active digital experts in your space is just the first step of the engagement planning cycle. Because even within a therapy area, digital KOLs (DOLs) have very different online characteristics – those who tend to initiate online conversations, those that tend to create new content, those that tend to propagate …

Measuring Advocacy of Digital KOLs Read More »

Improving KOL Virtual Advisory Board Engagements

“Very satisfied” is the consensus of KOLs who participate in our SkyBoard virtual advisory board events. But, from what KOLs tell us, there are also plenty of other ways to improve such virtual events. Before we go on to them, a brief note on terminology: by “Virtual Ad Board” we don’t just mean a live …

Improving KOL Virtual Advisory Board Engagements Read More »

Digital Awards sponsor push – press release for media partners

Want to be part of the leading digital healthcare awards, secure a sponsorship today! The PM Society’s Digital Awards, now in its 12th year, recognise the best in digital creativity, innovation and effectiveness from across the healthcare industry.   Why sponsor? *Be associated with the only annual Awards programme that highlights the best programmes, tools …

Digital Awards sponsor push – press release for media partners Read More »

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

During the last two decades, the landscape for psoriasis treatment has exploded. The advent of biologic therapies at the turn of the millennium and the subsequent development of T-cell targeted therapies and tumor necrosis factor (TNF) inhibitors have given patients therapeutic options beyond traditional treatments such as topical steroids, tar preparations, oral systemics, and light …

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor Read More »

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

During the last two decades, the landscape for psoriasis treatment has exploded. The advent of biologic therapies at the turn of the millennium and the subsequent development of T-cell targeted therapies and tumor necrosis factor (TNF) inhibitors have given patients therapeutic options beyond traditional treatments such as topical steroids, tar preparations, oral systemics, and light …

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor Read More »

Complex Medicines: A multi-billion-pound addition to the UK life sciences industry

 A new report published by Medicines Discovery Catapult and CPI details the huge medical and market potential for complex medicines in the UK   ‘Shaping the UK into an epicentre for complex medicines’ is a report by the Medicines Discovery Catapult (MDC) in partnership with the CPI showcasing the extensive potential for the UK in …

Complex Medicines: A multi-billion-pound addition to the UK life sciences industry Read More »

PRIYSM ID boosts customer service offer with new customer experience team

The regulated content and labeling software firm has made three new customer-facing appointments and created a brand-new Customer Experience Team to provide enhanced, end-to-end customer support for medical device and clinical trial organizations. Chief Executive Richard Adams says the creation of the new team reflects the company’s desire to improve the hands-on advice and assistance …

PRIYSM ID boosts customer service offer with new customer experience team Read More »

KOL Influence Maps

Who influences whom? Who’s connected to whom? Who collaborates with whom? These are some of the most important questions that should be answered when creating your target list of KOLs to engage with and building an effective KOL engagement strategy.   Traditionally most KOL influence maps have been built by analysing publication or congress co-authorship …

KOL Influence Maps Read More »

KOL Influence Maps

Who influences whom? Who’s connected to whom? Who collaborates with whom? These are some of the most important questions that should be answered when creating your target list of KOLs to engage with and building an effective KOL engagement strategy.   Traditionally most KOL influence maps have been built by analysing publication or congress co-authorship …

KOL Influence Maps Read More »

PRISYM ID joins Siemens Digital Industries Software Solution

The two firms are collaborating to create a unique, end-to-end labeling solution tailored for medical device organizations Wokingham, United Kingdom — 22nd June 2021 — Labeling software specialist PRISYM ID has joined the Siemens Digital Industries Software Solution Partner Program. Together with Siemens, they are working on a new hybrid solution designed to digitally integrate all labeling processes with …

PRISYM ID joins Siemens Digital Industries Software Solution Read More »

PRISYM ID joins Siemens Digital Industries Software Solution

The two firms are collaborating to create a unique, end-to-end labeling solution tailored for medical device organizations Wokingham, United Kingdom — 22nd June 2021 — Labeling software specialist PRISYM ID has joined the Siemens Digital Industries Software Solution Partner Program. Together with Siemens, they are working on a new hybrid solution designed to digitally integrate all labeling processes with …

PRISYM ID joins Siemens Digital Industries Software Solution Read More »

How do CDISC standards fit into the drug development process?

Introduction The clinical trial process is a long, expensive, complicated one that often ends in failure. This means that to have a successful outcome, careful decision making and planning are absolutely essential. And so are data standards! The FDA requires clinical study data to be submitted in a standardized format. This allows the FDA to …

How do CDISC standards fit into the drug development process? Read More »

How do CDISC standards fit into the drug development process?

Introduction The clinical trial process is a long, expensive, complicated one that often ends in failure. This means that to have a successful outcome, careful decision making and planning are absolutely essential. And so are data standards! The FDA requires clinical study data to be submitted in a standardized format. This allows the FDA to …

How do CDISC standards fit into the drug development process? Read More »

Piperacillin/tazobactam-induced coagulopathy in a patient through a vitamin K-dependent mechanism

Haematologic side effects associated with piperacillin/tazobactam (PTZ) treatment are rare but can be fatal. The exact mechanism by which PTZ causes haemorrhages has not been determined. We report the case of a patient who received PTZ treatment and developed a coagulopathy through a vitamin K-dependent mechanism. A 70-year-old female patient was admitted to the intensive …

Piperacillin/tazobactam-induced coagulopathy in a patient through a vitamin K-dependent mechanism Read More »

Deep 6 AI: the smart software breathing new life into clinical trials

Wout Brusselaers has spent his life on a quest to achieve one career goal—to work with smart people on a meaningful project that makes a difference to people’s lives. This mission saw him become a diplomat in the Middle East, a McKinsey consultant in Asia, and take on roles in international intelligence before realizing he could use his knowledge and skills in solving …

Deep 6 AI: the smart software breathing new life into clinical trials Read More »

Health Union Acquires WEGO Health

Health Union, the leader in building online health solutions for people living with chronic conditions, today announced that it has acquired WEGO Health, the world’s largest network of patient leaders – advocates, community leaders, creators and influencers. Combining Health Union’s targeted scale and depth in the condition experience with WEGO Health’s breadth of patient leaders …

Health Union Acquires WEGO Health Read More »

Foods, supplements, and medicine: the new frontier in chronic disease treatment

Chronic diseases are the biggest threat to our global socio-economic development. Lifestyle diseases including heart disease, neuro-degenerative disease, diabetes, and cancer collectively kill almost 50 million people per year.1 With 1 in 2 Americans diagnosed with pre-diabetes or type 2 diabetes, there is no doubt that the food we eat has implications not only for …

Foods, supplements, and medicine: the new frontier in chronic disease treatment Read More »

COUCH Health Engages Mark Duman as Chief Strategy Officer

COUCH Health, a patient engagement agency, announced the appointment of Mark Duman as its Chief Strategy Officer (CSO). Taking charge of strategy development and execution for COUCH Health, Mark will oversee the expansion of COUCH Health’s mission to contribute to inclusive clinical trials that prioritise the patient experience. Mark will report directly to CEO Ash …

COUCH Health Engages Mark Duman as Chief Strategy Officer Read More »

Building the hospital of the future

Every patient, every doctor or nurse, every hospital worker is a human being influenced by their experiences outside of healthcare. In the consumer world, we have all come to expect speed and interconnectedness, and value personalized products and services tailored to our lifestyles and needs. These expectations carry over into healthcare, where patients and healthcare professionals leverage a wide array of channels to …

Building the hospital of the future Read More »

PRISYM ID underlines its commitment to patient safety with updated GS1 certification

The latest version of the PRISYM 360 cloud-based labeling solution has achieved certification for the GS1 standards utilized by the medical device and life science industries. Wokingham, United Kingdom — 09th June 2021 — PRISYM ID, a leading provider of regulated labeling and content management solutions for the medical device and life science industries, has achieved GS1 certification …

PRISYM ID underlines its commitment to patient safety with updated GS1 certification Read More »

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. As part of our commitment to our clients, their customers, and their patients, we intentionally seek out and acquire best-in-class agencies that can help us further our services. Our ambitious growth …

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack Read More »

How Microsoft Teams streamlined cross-country forecasting for biotech pioneers.

J+D Forecasting has worked with one of Europe’s largest, leading biotechnology pioneers, helping to facilitate better, more collaborative forecasting for hundreds of colleagues across the continent. For the company’s most recent forecasting cycle, our experts have worked to incorporate Microsoft Teams as a core software, as well as extending Power BI, to enable regional users, and …

How Microsoft Teams streamlined cross-country forecasting for biotech pioneers. Read More »

G7 health summit highlights Oxfordshire’s thriving life sciences sector

The arrival of G7 health ministers to Oxford this week (Thursday 3 June) will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector – and, according to the county’s Local Enterprise Partnership, there couldn’t be a better location globally for this summit to be held. “Oxfordshire’s global role in the scientific response …

G7 health summit highlights Oxfordshire’s thriving life sciences sector Read More »

COUCH Health Finds Reasons Behind Underrepresentation of Minorities in US Clinical Trials

MANCHESTER, United Kingdom, May 20, 2021— COUCH Health, a patient engagement agency, has released new research exploring reasons behind the underrepresentation of ethnic minorities in US clinical trials. Also addressed are how clinical trial communication strategies can be improved to better engage people from diverse backgrounds and ethnicities. COUCH Health’s research findings suggest that participation from …

COUCH Health Finds Reasons Behind Underrepresentation of Minorities in US Clinical Trials Read More »

Formedix Expedites Clinical Trial Build with New Cloud Clinical MDR Suite

Glasgow, UK – (March 29, 2021) – Formedix, a leading provider of clinical trial software solutions, announces the launch of ryze, an innovative all-in-one cloud-based clinical metadata repository (MDR) and study automation platform. ryze has been specifically developed to accelerate and streamline the design, build and submission of clinical trials, in compliance with the Clinical …

Formedix Expedites Clinical Trial Build with New Cloud Clinical MDR Suite Read More »

3 Considerations for Pharma Brand Strategy Success

Change is coming in the digital marketing world whether you’re ready or not. New challenges are presented for marketers as privacy measures tighten and we say goodbye to cookies, yet this impending farewell also presents an invaluable opportunity to rejuvenate your pharma brand strategy. As healthcare marketers prepare for the switch to flip, one thing is …

3 Considerations for Pharma Brand Strategy Success Read More »

The 3rd Annual Blood-Brain Barrier Summit Returns in August 2021

The Blood-Brain Barrier Summit will take place online from June 28-30, 2021. This Hanson Wade event is aimed at experts looking to deliver CNS drug candidates safely and successfully across the blood-brain barrier (BBB). It will enable them understand the biology of the BBB, explore the latest technological innovations and develop more predictive preclinical models. …

The 3rd Annual Blood-Brain Barrier Summit Returns in August 2021 Read More »

Experts to come together for compliance event ‘validation ready’ global labeling systems  

Experts to come together for compliance event  exploring ‘validation ready’ global labeling systems      Wokingham, United Kingdom — 27 April 2021 — A group of industry experts is set to explore how medical device, clinical trial and pharmaceutical companies can proactively manage labeling risk. The complimentary online event, hosted by PRISYM ID, will explain best practice in the implementation of …

Experts to come together for compliance event ‘validation ready’ global labeling systems   Read More »

Healthware Group Acquires UK-Based SWM

SWM and Healthware Join Forces to Help Physicians Connect to Science & Learning Salerno, Italy / London, UK | 20 April 2021 – Healthware Group, an integrated global digital health organization with a focus on strategic consulting, marketing communications, and healthcare innovation has announced its acquisition of London-based SWM (Streaming Well Motion), a creative motion …

Healthware Group Acquires UK-Based SWM Read More »

J+D Forecasting provides Online Team Pharma Forecasting Training

Following the success of J+D’s face to face training, the content has been redesigned to make it suitable for an online audience. The training can be tailored to individual teams/departments within specific organisations or completed independently. There is a significant need for an improved approach to pharmaceutical forecasting. Improved model design, enhanced usability, efficient processes …

J+D Forecasting provides Online Team Pharma Forecasting Training Read More »

Mapping Voices

Instead of thinking about mapping KOLs and stakeholders, consider thinking about mapping all the “voices” in your disease ecosystem.   A voice that impacts, influences, or inspires the success of your brand could encompass everything from traditional KOLs to nursing pacesetters, from long-established patient groups to transient on-line communities, from high-thinking academics to high-tweeting clinicians, …

Mapping Voices Read More »

Meet our new Chair Deborah Keller

Deborah Keller is a dynamic woman who gives off an immediate sense of warmth and humor. The moment she joined our video chat, she began sharing stories about her life in lockdown, admitting to feeling so cooped up that she painted her laundry room at 9 pm the night before. However, underneath her easy-going exterior …

Meet our new Chair Deborah Keller Read More »

Meet our new Chair Deborah Keller

Deborah Keller is a dynamic woman who gives off an immediate sense of warmth and humor. The moment she joined our video chat, she began sharing stories about her life in lockdown, admitting to feeling so cooped up that she painted her laundry room at 9 pm the night before. However, underneath her easy-going exterior …

Meet our new Chair Deborah Keller Read More »

Making a big impact in small patient populations

Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves1. Advances in next-generation sequencing have shown that sequencing the whole genomes of large numbers of individuals in a standardized way can improve the diagnosis and treatment of patients with rare diseases. Scientists have …

Making a big impact in small patient populations Read More »

Making a big impact in small patient populations

Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves1. Advances in next-generation sequencing have shown that sequencing the whole genomes of large numbers of individuals in a standardized way can improve the diagnosis and treatment of patients with rare diseases. Scientists have …

Making a big impact in small patient populations Read More »

Continuity of Care in a Pandemic: Reflecting on the Rise of Telehealth

March 2021 comes with mixed emotions, as people across the United States reflect on one year of life in the era of COVID-19. From a rollercoaster of lockdown restrictions, isolation, mask-wearing and socially distancing, to finally experiencing a glimmer of hope with increasing vaccine distribution – it’s safe to say the past 12 months have …

Continuity of Care in a Pandemic: Reflecting on the Rise of Telehealth Read More »

Continuity of Care in a Pandemic: Reflecting on the Rise of Telehealth

March 2021 comes with mixed emotions, as people across the United States reflect on one year of life in the era of COVID-19. From a rollercoaster of lockdown restrictions, isolation, mask-wearing and socially distancing, to finally experiencing a glimmer of hope with increasing vaccine distribution – it’s safe to say the past 12 months have …

Continuity of Care in a Pandemic: Reflecting on the Rise of Telehealth Read More »

Drug Discovery Leader Dr Nicola Heron

Drug Discovery Leader Dr Nicola Heron on Championing Innovation and Diversity in the Sector Medicines Discovery Catapult’s newly appointed Chief Business Officer, Dr Nicola Heron MBA sets out her intention to support up-and-coming innovators in early stage drug discovery and to ensure diversity is a key part of the innovation agenda for MDC. Having spent …

Drug Discovery Leader Dr Nicola Heron Read More »

Arist Optimizes Text Messaging Platform for the Life Sciences Industry

Life sciences organizations can easily send customizable, templated text messages and digital assets without compromising compliance Arist, developers of an innovative enterprise-level text messaging platform for education, training and outreach, has announced that its technology has been optimized to better meet the needs of the life sciences industry. The updated Arist platform enables life sciences …

Arist Optimizes Text Messaging Platform for the Life Sciences Industry Read More »

UDG Healthcare acquires market access, HEOR specialist, PHMR Limited as Ashfield Advisory

Ashfield Advisory, part of UDG Healthcare plc, today announced the acquisition of PHMR Limited, a Market Access Consultancy and specialist in Health Economics and Outcomes Research (HEOR) Within Ashfield Advisory, PHMR will join forces with Putnam Associates, who specialise in strategy consulting exclusively for the biopharmaceutical and medical device industries. This will strengthen Putnam’s global …

UDG Healthcare acquires market access, HEOR specialist, PHMR Limited as Ashfield Advisory Read More »

Ashfield Advisory launches its Advisory Ecosystem in response to market demand

Today, Ashfield Advisory, a business unit of Ashfield, part of UDG Healthcare, plc., outlines its new Advisory Ecosystem Model. The Ashfield Advisory businesses – Vynamic, Putnam Associates, STEM Healthcare and SmartAnalyst – combine their expertise to provide specialist, yet integrated services to customers spanning insight, strategy, action and evaluation. Ashfield has built the Advisory platform …

Ashfield Advisory launches its Advisory Ecosystem in response to market demand Read More »

Three strategies for managing loss of exclusivity successfully

“Patent losses could sink Allergan”.1 “Drug prices to plummet in wave of expiring patents”.2 “Price decay after loss of brand exclusivity”.3 These are just three headlines that come up when you Google “drug patent expiry”.4 It’s no wonder “loss of exclusivity (LOE)” or “the patent cliff” is an ominous prospect for drug manufacturers – shrouded …

Three strategies for managing loss of exclusivity successfully Read More »

Relationship Advice: What Patients Want HCPs to Know About Satisfaction

What aspects of a patient’s treatment matter most? For many, healthcare providers (HCPs) make a significant impact on how a person feels about their overall care plan; a positive HCP-patient relationship can help a person feel in control of their health and more prepared for the journey ahead, while a less than ideal HCP-patient relationship …

Relationship Advice: What Patients Want HCPs to Know About Satisfaction Read More »

Ashfield Engage launches with an integrated offering to maximize engagement

Ashfield Engage, a business unit of Ashfield, part of UDG Healthcare plc., today launches as an engagement and commercialization partner for the healthcare industry. Previously ‘Ashfield Commercial and Patient Solutions’, the business has grown and enhanced its capabilities across five specialist areas:  Medical Affairs, Market Access*, Commercial, Patient Solutions, and Event Experiences. Driven by customer …

Ashfield Engage launches with an integrated offering to maximize engagement Read More »

Building early relationships: a gamechanger for pioneering rare disease treatment

Advocacy groups play a crucial role in both driving access to innovative treatment and services and educating patients and caregivers on novel breakthroughs. On average, it takes more than four years to receive an accurate diagnosis of a rare disease.1 This diagnostic odyssey has pushed patients and caregivers online to self-diagnose and learn more about …

Building early relationships: a gamechanger for pioneering rare disease treatment Read More »

Ashfield advances integrated service offering with three new business units

Newly formed Ashfield Advisory, Ashfield Engage and Ashfield Health enable deeper partnerships and cross-collaborative solutions for customers Ashfield, part of UDG Healthcare plc, today announced the formation of three business units to bolster its integrated healthcare services across strategic consulting, benchmarking, commercialisation, customer engagement, events, marketing and communications. The creation of the three business units; …

Ashfield advances integrated service offering with three new business units Read More »

Ashfield Healthcare Communications rebrands as Ashfield Health

President. Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network. Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency. Ashfield Health’s 14 medical and scientific communications agencies come …

Ashfield Healthcare Communications rebrands as Ashfield Health Read More »

The Difference Between KOL Identification And KOL Mapping

KOL identification and KOL mapping are often spoken about together, often treated as the same entity would simply a difference in terminology. They are however very different, yet synergistic.   KOL identification is about identifying those that can impact your work – clinicians, authors, speakers, nurses, tweeters, or the medics building cutting edge apps. KOL …

The Difference Between KOL Identification And KOL Mapping Read More »

The Year Of Virtual Co(Creation)

If 2020 was the year that cemented the role of virtual advisory boards and virtual engagement in many forms, then we believe that 2021 will be the year of ‘virtual co-creation’. The benefits of virtual advisory boards (VABs) in replacing face-to-face advisory discussion with KOLs and HCPs are now clear and established. But there are …

The Year Of Virtual Co(Creation) Read More »

Wilmington Healthcare launches new platform to map the formulary landscape

Healthcare intelligence provider Wilmington Healthcare has launched a new platform that enables pharma companies to develop a clear picture of formulary status across therapy areas and territories in the UK.   Known as InFormulary XD, the solution uses a unique blend of data and real-world evidence to provide an objective view of the status of …

Wilmington Healthcare launches new platform to map the formulary landscape Read More »

Italy eyes Digital Therapeutics

The recommendations for the Country’s pathway towards DTx are captured in the White Paper “Digital Therapeutics, an Opportunity for Italy” The official journal of the Smith Kline Foundation, Tendenze Nuove, published the White Paper “Digital Therapeutics, an Opportunity for Italy” on 13 January 2021. The book consists of 208 pages featuring insights and recommendations from …

Italy eyes Digital Therapeutics Read More »

A study to avoid chemotherapy in patients with early HER-2+ breast cancer

MEDSIR, a global company dedicated to independent clinical research in oncology, has initiated the PHERGain II clinical trial to demonstrate that in patients with HER2-positive early breast cancer with a good prognosis, a chemotherapy-free therapeutic approach can be as effective as the current standard of care, which involves the use of this generally more toxic …

A study to avoid chemotherapy in patients with early HER-2+ breast cancer Read More »

Pulse Infoframe Releases Registry for Patient Advocacy Groups

Launching a rare disease patient registry often requires patient advocacy groups to design a registry themselves or pay for an expensive customized solution. With the launch of Rare Central, Pulse Infoframe offers patient advocacy groups an on-ramp to collecting real-world data, including natural history data, disease-specific data, and patient-reported outcomes. As a patient group’s needs …

Pulse Infoframe Releases Registry for Patient Advocacy Groups Read More »

5 Ways to Make Your Pharma Marketing More Personal

Personalization in marketing–the practice of understanding and delivering content when and where people are ready to accept it–in any industry is key, but perhaps even more so in healthcare. If we’ve learned anything as marketers in 2020, this new landscape demands personalization to break through the noise and reach and engage with people during their …

5 Ways to Make Your Pharma Marketing More Personal Read More »

Sector specialism is essential for clinical labeling solutions

PRISYM ID’s Chief Executive Richard Adams has said that to meet the unique labeling and product information needs of the life science industry it has never been more important for regulated labeling technology companies to draw on deep, specialized knowledge and experience of the sector to enable it to continue to deliver the unmatched standards …

Sector specialism is essential for clinical labeling solutions Read More »

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance

By Jennifer Mercer, CEO of Metazoa Jennifer Mercer is Co-founder and CEO of Metazoa, developers of Snapshot, an admin and developer tool for companies with complex Salesforce orgs that is used by over 60% of Fortune 100 companies.  Salesforce org management is usually not the headliner for CIOs and CTOs looking to catch up on …

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance Read More »

Capital Rx Secures $50 Million to Redefine Prescription Pricing

What You Should Know: – Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today that it has raised $50 million in Series B financing. – Following the recent launch of JUDITM, the industry’s first Enterprise Pharmacy Platform, Capital Rx will continue to expand the platform’s capabilities, including leveraging AI to improve clinical …

Capital Rx Secures $50 Million to Redefine Prescription Pricing Read More »

3 things you should know about ADaM standards

One of the most important standards when it comes to clinical trial submission is the Analysis Data Model (ADaM). It outlines how to create analysis datasets and associated metadata. This in turn allows a statistical programmer to generate tables, listings, and figures (TLFs) more easily and ensures traceability. That means that reviewers can review and approve …

3 things you should know about ADaM standards Read More »

RxSource optimizes clinical labeling process with PRISYM 360 cloud-based solution

The Covid-19 pandemic has put further pressure on clinical trial suppliers to be fleet of foot in getting products dispatched when a new patient is recruited, as studies for vaccines have been set up and run at unprecedented speed.    For PRISYM ID client RxSource, a Global Clinical Trial Supplies Specialist, it means being ready to partner with sponsor …

RxSource optimizes clinical labeling process with PRISYM 360 cloud-based solution Read More »

What does the future hold for Medical Affairs?

“A new medical affairs communication model is emerging that provides greater collaboration and stakeholder engagement” I am a clinical pharmacist by training, but my interest lies in drug information. I found out about medical communications when working in the Drug Information Center at the Medical College of Virginia Hospitals. A colleague of mine offered to …

What does the future hold for Medical Affairs? Read More »

Mistrust in medical research: a patient perspective

In medical research, trust has traditionally been hard-fought for. Terms like “lab rats” and “guinea pigs” are often used in conversations about clinical trials. For some communities, the historic unethical treatment of participants is also still a raw memory[1]. People tend to remember when things go wrong, and this casts doubt over procedures and leads …

Mistrust in medical research: a patient perspective Read More »

Unpacking rare diseases in the first edition of Delta magazine

Welcome to Delta – the new Fishawack Health magazine. We’ve chosen to focus our first edition of the magazine on a topic close to our hearts, rare diseases. Rare diseases represent an incredibly high unmet need, not only due to the lack of therapies and the practical difficulties in diagnosis, but also in patients’ desire …

Unpacking rare diseases in the first edition of Delta magazine Read More »

Real-world evidence: breaking boundaries in rare disease

The COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have been delayed and clinical trials have been postponed or suspended. As a result, life sciences companies are turning to novel methods of collecting clinical data and innovative trial design. The generation of data to show the significant …

Real-world evidence: breaking boundaries in rare disease Read More »

First Psychiatry Consortium funded project announced for schizophrenia

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia. This is the first project to be funded by the international Psychiatry Consortium, a £4 million collaboration between seven global pharmaceutical companies, …

First Psychiatry Consortium funded project announced for schizophrenia Read More »

Testing Lab Data Reveals Spread of New Covid Variant Across the Country

Scientists at the Alderley Park Lighthouse Lab in Cheshire have revealed the speed and scale at which the new variant of the COVID virus is spreading through communities across the country. https://pharmaphorum.com/wp-content/uploads/2021/01/S-gene-dropout-animation.mp4 The Lighthouse, operated by Medicines Discovery Catapult (MDC) and launched last April, plays a key role in the UK Government’s national COVID testing …

Testing Lab Data Reveals Spread of New Covid Variant Across the Country Read More »

Using Define-XML for Dataset Design

In the past, sponsors submitting to FDA were required to submit a PDF describing their submission datasets. As we all know PDF is great for viewing on-screen or printing, but the information inside can’t be interpreted by a computer. Enter CDISC’s Define-XML model. Define-XML standardizes how to describe datasets in a machine-readable manner. It can …

Using Define-XML for Dataset Design Read More »

UK Innovators Target Nanoparticles at Inoperable Cancers

Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project At a point of critical clinical need for improved treatments for pancreatic and head and neck cancers, a partnership of healthcare innovators set out to revolutionise radiotherapy for inoperable, and the most difficult to treat tumours. With the aim of …

UK Innovators Target Nanoparticles at Inoperable Cancers Read More »

Patient experiences are evolving. How can pharma keep up?

By listening to the people who are navigating this new landscape everyday.Integrating personal experiences and patient-reported data, Health Union recently hosted a one-day virtual event entitled The COVID-19 Effect: How Pharma Can Adapt to the Evolving Patient Experience, featuring real-time conversations between people living with chronic conditions and industry experts. The sessions focused on the …

Patient experiences are evolving. How can pharma keep up? Read More »

Machine-learning, robotics and biology to deliver drug discovery of tomorrow

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment. Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs …

Machine-learning, robotics and biology to deliver drug discovery of tomorrow Read More »

Survey Finds Telehealth Is Convenient Alternative, Will Likely Continue Beyond the Pandemic

A new Health Union survey reveals that people with chronic conditions feel that telehealth, despite its convenience and increased use throughout the COVID-19 pandemic, is generally less preferable than in-person visits, but can still serve as an occasionally suitable alternative. The survey is the fifth in Health Union’s ongoing COVID-19 Consumer Attitudes and Health Behaviors …

Survey Finds Telehealth Is Convenient Alternative, Will Likely Continue Beyond the Pandemic Read More »

PRISYM 360 Achieves SAP® Certification as Integrated with Cloud Solutions from SAP

PRISYM 360 Achieves SAP® Certification as Integrated with Cloud Solutions from SAP The latest version of the PRISYM 360 intelligent data import connector now has SAP-certified integration using SAP Cloud Platform Integration Suite Wokingham, United Kingdom — 7 December 2020 — PRISYM ID, a leading provider of regulated content and label management solutions for the life …

PRISYM 360 Achieves SAP® Certification as Integrated with Cloud Solutions from SAP Read More »

First results of the DiabetRisk study

First results of the DiabetRisk study – Over 8% of patients identified with undiagnosed diabetes or pre-diabetes at dental practices The DiabetRisk study could contribute to early diagnosis of diabetes in thousands of dental patients each year – and in every country worldwide Simple screening process applied to 1,143 dental patients at 41 dental practices …

First results of the DiabetRisk study Read More »

Healthware Group announces acquisition of Make Helsinki

Healthcare agency, consultancy and digital health group, Healthware, has announced the acquisition of Finland-based digital service development and creative agency Make Helsinki. Healthware strengthens its geographical coverage with the creation of a hub dedicated to the Nordics and Baltics region The deal combines Healthware’s consulting, full-service agency and digital health capabilities with Make Helsinki’s additional …

Healthware Group announces acquisition of Make Helsinki Read More »

How a clinical metadata repository can help with data quality

Metadata comes from multiple sources and can be stored in different places, systems, and networks. It’s hard to track it down. When files are updated, new versions are created. So how do you know if you’ve got the latest version? How do you know if the quality is good enough? The easiest way is to …

How a clinical metadata repository can help with data quality Read More »

Havas Health & You launches Behind the Mask

Behind the Mask is a global research initiative to document health experiences during the COVID-19 pandemic and beyond. Havas Health & You (HH&Y) has launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study that focuses on documenting the ongoing evolution of health and wellness. This sector has seen …

Havas Health & You launches Behind the Mask Read More »

Measuring And Tracking KOL Advocacy

Measuring and tracking advocacy amongst your KOLs is of critical importance to help ensure effective engagement. It is also an important measure of ROI – it enables you to see how your activities have ‘changed the needle’ and what impact they have had on KOLs.   How can you measure and track advocacy? Our Advocacy …

Measuring And Tracking KOL Advocacy Read More »

35th PM Society Awards – now open for entries

2021 will be the 35th anniversary of the PM Society Awards where we recognise the best in creativity, impact and innovation across communications within the healthcare industry.  These awards highlight the best creative campaigns, programmes and tools used in pharmaceutical promotion, patient and HCP communication, disease awareness and internal training and engagement. This year we …

35th PM Society Awards – now open for entries Read More »

Great creative is effective creative. And effective creative is affective creative

Our creative philosophy has always been simple. To produce works that works. Effective, impactful brand communications that deliver tangible results. As the great adman Bill Bernbach said: “If it doesn’t sell, it isn’t creative.” And if you want to sell or change behavior, you need to reach your target audience with evocative creativity. That’s why we …

Great creative is effective creative. And effective creative is affective creative Read More »

University of Exeter and Medicines Discovery Catapult in strategic partnership

Today, the University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value for the sector and enhancing translational skills. MDC is the national centre for technology, innovation and adoption for medicines R&D and, in collaboration with the University of Exeter and its ground-breaking researchers, …

University of Exeter and Medicines Discovery Catapult in strategic partnership Read More »

Leading digital health conference Frontiers Health 2020 in partnership with Healthware witnesses the global acceleration of digital health

Frontiers Health, held on November 12-13th, kicks off globally with a comprehensive agenda of 60+ sessions by 200 top speakers dedicated to the most relevant topics in digital health innovation, including over 100 start-ups and scale-ups that made it through the selection process. An overarching theme of the event will be exploring how digital health …

Leading digital health conference Frontiers Health 2020 in partnership with Healthware witnesses the global acceleration of digital health Read More »

5 Things Patient Advocates Want Pharma and the Healthcare Industry to Know

The COVID-19 pandemic has presented many obstacles, yet the healthcare industry continues to march forward to meet the needs of patients. With physical distancing, new office protocols and the widespread use of telehealth, the patient experience is changing–particularly for people living with chronic conditions, who may require more regular access to care. To truly understand …

5 Things Patient Advocates Want Pharma and the Healthcare Industry to Know Read More »

COMPASS Pathways Joins the Psychiatry Consortium

Boost for Mental Health Medicines R&D as COMPASS Pathways Joins the Psychiatry Consortium Global mental health care company, COMPASS Pathways plc has joined the Psychiatry Consortium, bringing additional expertise and insights to the group. A company dedicated to accelerating patient access to evidence-based innovation in mental health, COMPASS Pathways will further enhance the Consortium’s collective …

COMPASS Pathways Joins the Psychiatry Consortium Read More »

Identifying Rising Stars – The Importance Of Methodology And Context

Identifying and engaging with emerging experts and rising stars is a key part of medical affairs. Their role and value in supporting the successful clinical journey of a molecule is well established. What is less established however, is the importance of balancing “methodology” and “context” when it comes to identifying and mapping the rising star …

Identifying Rising Stars – The Importance Of Methodology And Context Read More »

How to make an impact at a virtual congress

More competition than ever before The pharmaceutical industry has long relied on congresses to build relationships with customers and to showcase the latest data and information on new additions to the pipeline. However, COVID-19 has changed the congress experience significantly. Social distancing and travel restrictions have forced congress organizers to make a tough decision between …

How to make an impact at a virtual congress Read More »

Fostering Confidence in Newly Diagnosed Autoimmune Patients

When a person is newly diagnosed with an autoimmune condition, such as psoriasis or rheumatoid arthritis, it’s not uncommon for us to hear from them in our online health communities discussing fear or uncertainty, and seeking connection or support. The myriad of difficult decisions they are making around treatment options may foster a sense of self-doubt, and …

Fostering Confidence in Newly Diagnosed Autoimmune Patients Read More »

Using SDTM, ADaM, and SEND for Regulatory Submissions

It’s a safe bet that most people’s first introduction to CDISC standards is through the Study Data Tabulation Model (SDTM). This is a content standard that ensures clinical data is submitted in a consistent manner, helping to reduce review time and facilitating cross-study analysis. Another content standard, the Analysis Data Model (ADaM), aims to perform …

Using SDTM, ADaM, and SEND for Regulatory Submissions Read More »

J+D FORECASTING LAUNCHES INTELLIGENT DATA

J+D Forecasting, known as the experts in pharmaceutical forecasting, has today announced the launch of EpiCube; the latest addition to its comprehensive suite of pharmaceutical forecasting products. Unlike most standard epidemiological databases available, EpiCube is the first database where the user can choose how to build their own data set; be that by country, disease, …

J+D FORECASTING LAUNCHES INTELLIGENT DATA Read More »

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

October is ADHD Awareness Month, and retired NFL linebacker J.T. Thomas wants people to know that it is okay to get help for the treatment of attention deficit hyperactivity disorder (ADHD). As a person with ADHD, J.T. Thomas knows how important getting help is, and why overcoming obstacles such as stigma, access to care and …

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done Read More »

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done

October is ADHD Awareness Month, and retired NFL linebacker J.T. Thomas wants people to know that it is okay to get help for the treatment of attention deficit hyperactivity disorder (ADHD). As a person with ADHD, J.T. Thomas knows how important getting help is, and why overcoming obstacles such as stigma, access to care and …

Retired NFL Linebacker Overcomes ADHD, Invests in Mental Health Platform Done Read More »

Exclusive Pharma Microbiology interview with Maria Jose Lopez Barragan, formerly at FDA

SMi Reports: An exclusive interview with María José López Barragán, Founder, Barragan BioConsulting, formerly CMC Product Quality Reviewer, FDA, who will be speaking at the 3rd Annual Pharmaceutical Microbiology East Coast Conference released. The Pharmaceutical Microbiology Conference East Coast Virtual Conference will be commencing on 28th and 29th October 2020 and will focus on technological …

Exclusive Pharma Microbiology interview with Maria Jose Lopez Barragan, formerly at FDA Read More »

PRISYM ID appoints Software Delivery Manager to oversee clinical labeling team

PRISYM ID appoints Software Delivery Manager to oversee team developing new clinical labeling solutions     Wokingham, United Kingdom — 30 September 2020 — PRISYM ID, a leading provider of regulated content and label management solutions, has announced the appointment of Amresh Bangalore as Software Delivery Manager. In his new role, Amresh will be responsible for overseeing and coordinating the people, resources and processes required to deliver new solutions and upgrade existing products, primarily around the …

PRISYM ID appoints Software Delivery Manager to oversee clinical labeling team Read More »

Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020

SMi reports: Alan Franklin, CEO, ForwardVue Pharma will be presenting at the Ophthalmic Drugs conference The 4th Annual Ophthalmic Drugs Conference taking place on the 23rd -24th November 2020, will explore new discoveries in the treatment of ocular disease, innovations in combination technologies, and the utterly unique challenges that are faced in the treatment of …

Exclusive interview with ForwardVue Pharma released for Ophthalmic Drugs 2020 Read More »

Pharma Microbiology East Coast Conference – A Virtual Conference with Remote Access

SMi’s Pharmaceutical Microbiology East Coast Conference – A Virtual Conference with Remote Access Only SMi Reports: SMi Group have made the decision due to travel restrictions to open the conference and workshops to all microbiologists by transforming it into a virtual-remote online access event only on October 28 and 29 2020. SMi’s 3rd Annual Pharmaceutical …

Pharma Microbiology East Coast Conference – A Virtual Conference with Remote Access Read More »

Qualitative KOL Mapping

If you were trying to identify the most influential people within a large and active Facebook group, would you restrict yourself to analysing “number of posts” and other quantitative metrics only?   In such situations, adding a variety of qualitative inputs – to balance the objective with the subjective – can uncover and yield additional …

Qualitative KOL Mapping Read More »

Swittons Introduces Smart IoT Devices for Pharmaceutical Lab Digital Transformation Initiatives

Swittons, a P360 company, has announced a new line of Internet of Things (IoT) enabled smart devices built specifically for pharmaceutical labs. The fully customizable devices align with strategic Lab of the Future(LoTF) initiatives and help automate various laboratory workflows between people and existing digital lab equipment, systems and solutions. Built on an agile technology …

Swittons Introduces Smart IoT Devices for Pharmaceutical Lab Digital Transformation Initiatives Read More »

J+D Forecasting strike the balance for the liquid tumour market

J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market The Challenge Identify a clear, transparent, and logical way to structure a forecast model to identify the potential for a new therapy in leukaemia. The model would be complex because patients go through different stages of treatment within a …

J+D Forecasting strike the balance for the liquid tumour market Read More »

Medicines Discovery Catapult awarded funding to establish Cheshire & Warrington medicines powerhouse

Today [11 August 2020], Medicines Discovery Catapult (MDC) announce that it has been awarded government seedcorn funding; provided through UK Research and Innovation’s flagship £236m Strength in Places Fund, along with project partner Cheshire & Warrington Local Enterprise Partnership (LEP). The funding will be used to create a regional consortium and develop the full stage …

Medicines Discovery Catapult awarded funding to establish Cheshire & Warrington medicines powerhouse Read More »

Survey finds quality control is a major challenge in clinical labeling

Many respondents experience frequent problems and blame human error Wokingham, United Kingdom — 6 August 2020 A survey conducted among global healthcare companies by PRISYM ID, a leading provider of data-led label and artwork management solutions, shows that a fifth of them experience quality control issues with clinical labeling on a monthly basis. The survey, which included …

Survey finds quality control is a major challenge in clinical labeling Read More »

J+D Forecasting Change the Forecasting Approach of a Global Bio Tech

Background One of the world’s global biotechnology companies a leader, in innovative scientific research in rare diseases, approached J+D Forecasting with a set of forecasting challenges. J+D Forecasting had worked with the team previously to build better forecast models. Key improvements at this point focused on model structures, methodology, transparency, and alignment to best practice. …

J+D Forecasting Change the Forecasting Approach of a Global Bio Tech Read More »

Playing an Active Role in Treatment Yields More Confidence in Patients

When aiming to reach the people who will benefit most from a given medication or therapy, patients who play an active role in treatment decisions are often at the forefront of the conversation. But what does playing an active role in treatment really mean? While there is no concrete definition, a meta-analysis of Health Union’s …

Playing an Active Role in Treatment Yields More Confidence in Patients Read More »

Pre-filled Syringes San Francisco will now take place as a Virtual Conference

SMi Reports: Due to the ongoing challenges surrounding COVID-19 and large public gatherings, September’s Pre-filled Syringes San Francisco conference will now run as a virtual event. With the continued uncertainty surrounding large gatherings in the UK, SMi Group have made the decision to turn the pre-filled Syringes Conference on the 14h – 15th September 2020 …

Pre-filled Syringes San Francisco will now take place as a Virtual Conference Read More »

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop

SMi reports: Brian Levy, CEO, Ocunexus Therapeutics will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the 4th Annual Ophthalmic Drugs Conference taking place on the 23rd -24th November 2020, in London. SMi are also pleased to announce that they will be hosting a half-day post-conference workshop, Wednesday 25th November 2020 …

Ophthalmic Drug Delivery Development – Trials and Tribulations workshop Read More »

The Elusive KOL Pyramid

The traditional KOL pyramid – you know the one, with the most influential global experts at the top and the front-line national HCPs lower down – is an important construct when identifying and mapping experts. But its simplicity sometimes hides the complexity of real-life. Consider, for example, how this traditional KOL pyramid flips as you …

The Elusive KOL Pyramid Read More »

New speaker session with Kiniksa Pharmaceuticals at Pre-filled Syringes East Coast 2020

SMi Reports: new speaker session with Paul Roussel, Senior Director, Combination Products, at the Pre-filled Syringes East Coast 2020 conference I am pleased to inform you that Paul Roussel, Senior Director, Combination Products, Kiniksa Pharmaceuticals, has confirmed his position as speaker at the conference. Paul’s presentation is as follows: Development of a Combination Product- A …

New speaker session with Kiniksa Pharmaceuticals at Pre-filled Syringes East Coast 2020 Read More »

Managing and Tracking Cross-functional KOL Collaborations

It’s often the case that different functions within your organisation are working with the same KOLs – whether it’s across indications, franchise, or even R&D.   While essential to brand success, cross-functional collaboration also poses several challenges when it comes to managing and tracking your interactions with KOLs. And we often hear a similar set …

Managing and Tracking Cross-functional KOL Collaborations Read More »

Understanding COVID-19 and varying responses across the globe

While lockdown eases across England, local lockdowns are becoming an ever-growing threat across the country. This is a unique response in comparison to other countries across the world and could be indicative of a second spike in infections. At the beginning of the pandemic, The London School of Hygiene and Tropical Medicine launched a course …

Understanding COVID-19 and varying responses across the globe Read More »

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER

FC+, a suite of Excel add-ins, specifically designed for Pharma Forecasting has been upgraded   J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the release of several pharmaceutical forecasting software upgrades. The unique Excel software has been specifically created for anyone involved in Pharmaceutical forecasting, to produce forecast models quickly …

J+D FORECASTING MAKES THE PHARMA FORECASTING EXPERIENCE EVEN BETTER Read More »

If our patients are diverse, why are clinical trials so white?

  How many times have you been told to put on sunscreen to prevent skin cancer? About 71% of US adults use some form of sun protection when outdoors on a warm, sunny day – an increase of 3% from 2008. Now, what if I told you that despite these public health initiatives to increase …

If our patients are diverse, why are clinical trials so white? Read More »

Exclusive Interview Matts Ramstorp Chair for SMi’s Next Generation Pharmaceutical Cleanroom

SMi Reports: Interview with Matts Ramstorp, Professor in Cleanroom Technology, BioTekPro, chairing the upcoming SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom in London on 7 – 8 October 2020. The 2nd Annual Next Generation Pharmaceutical Cleanroom Conference is taking place in London, UK on the 7 and 8 October 2020. SMi are proud to introduce …

Exclusive Interview Matts Ramstorp Chair for SMi’s Next Generation Pharmaceutical Cleanroom Read More »

Novel Platforms in Ocular Drug Delivery workshop discussed at Ophthalmic Drugs

SMi reports: Dr. Thakur Raghu Raj Singh from Queen’s University Belfast will lead the post conference workshop on Wednesday 25th November 2020. SMi presents the 4th Annual Ophthalmic Drugs Conference taking place on the 23rd -24th November 2020, in London. SMi are also pleased to announce that they will be hosting a half-day post-conference workshop, …

Novel Platforms in Ocular Drug Delivery workshop discussed at Ophthalmic Drugs Read More »

Featured speakers for 2nd annual Wearable Injectors and Connected Devices Conference

SMi Reports: Featured Speakers listed for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place in October. The global wearable devices market size is expected to reach a value of $62.82 billion USD by 2025 with time dependent delivery, improved patient experience and adherence and large volume administration with minimal injection pain …

Featured speakers for 2nd annual Wearable Injectors and Connected Devices Conference Read More »

Developing custom syringes for highly viscous formulations discussed at PFS San Francisco

SMi Reports: ‘Developing custom syringes for highly viscous formulations’ one of the many topics to be presented at the inaugural Pre-filled Syringes San Francisco Conference on September 14 and 15. SMi Group is holding the inaugural Pre-filled Syringes San Francisco virtual conference, taking place on the 14th and 15th September 2020, in San Francisco, USA. …

Developing custom syringes for highly viscous formulations discussed at PFS San Francisco Read More »